NAC (N-Acetyl Cysteine): Clinical Evidence & Substantiation Summary

Clinical Trials
53
Strongest Evidence
Antioxidant & Detoxification
Typical Dosage
600–1,800 mg/day
Common Forms
NAC (N-Acetyl-L-Cysteine) powder

What Is NAC (N-Acetyl Cysteine)?

N-Acetyl Cysteine (NAC) is a bioavailable form of the amino acid L-cysteine and a precursor to glutathione, the body's master antioxidant. It has a long clinical history — originally used as a mucolytic agent — and is now widely studied for its antioxidant, detoxification, and respiratory support properties.

Mechanism of action: NAC replenishes intracellular glutathione (GSH) by providing cysteine, the rate-limiting amino acid in GSH synthesis. It directly scavenges free radicals, modulates the inflammatory NF-κB pathway, breaks disulphide bonds in mucus glycoproteins (mucolytic effect), and supports phase II liver detoxification enzymes.

Clinical Evidence Summary

Below are 5 key clinical studies on NAC (N-Acetyl Cysteine). Nutra Comp analyses 53+ studies in its full clinical evidence report.

Multi-centre analysis2015PMID: 25920418

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study

Population: 11,195 patients

Key finding: NAC remains the gold standard for acetaminophen-induced hepatotoxicity, demonstrating significant hepatoprotective effects.

Systematic review and meta-analysis2019PMID: 30782299

N-acetylcysteine as an adjunct to antidepressants: A systematic review and meta-analysis

Population: 5 RCTs, 574 participants

Key finding: NAC as adjunct therapy significantly improved depressive symptoms vs. placebo (SMD -0.37, p=0.02).

Systematic review2017PMID: 28895666

Oral N-acetylcysteine supplementation and exercise performance: a systematic review

Population: 12 studies

Key finding: NAC supplementation showed some benefit in delaying fatigue during prolonged exercise, potentially via reduced oxidative stress and glutathione replenishment.

Systematic review2019PMID: 31028372

N-Acetylcysteine in COPD: A Review of Its Potential as Mucolytic and Antioxidant

Population: Multiple RCTs

Key finding: NAC at 600–1,200 mg/day significantly reduced exacerbation frequency in COPD patients and improved respiratory function markers.

Systematic review2016PMID: 27117852

Effect of N-acetylcysteine on oxidative stress markers: a systematic review

Population: 18 studies

Key finding: NAC supplementation significantly increased blood glutathione levels and reduced markers of oxidative stress (MDA, 8-OHdG) across multiple populations.

Evidence-Based Structure–Function Claims

Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.

9
Supports the body's natural antioxidant defences by promoting glutathione production
Category: Antioxidant · Confidence: 9/10
8
Supports healthy respiratory function and mucus clearance
Category: Respiratory · Confidence: 8/10
8
Supports healthy liver function and detoxification processes
Category: Liver Health · Confidence: 8/10

Get the full substantiation report for NAC (N-Acetyl Cysteine)

Includes all 53+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.

Join Waitlist for Full Access

Related Ingredients

Vitamin C
168 studies · Immune Function
Alpha-Lipoic Acid (ALA)
52 studies · Blood Sugar Support

Key Terms

SubstantiationRandomised Controlled Trial (RCT)P-Value

Frequently Asked Questions

Is NAC FDA approved?

NAC has a complex regulatory history. It is FDA-approved as a prescription drug (Mucomyst) for acetaminophen overdose. Its status as a dietary supplement ingredient has been debated by the FDA, but it remains widely available as a supplement. Brands should monitor FDA guidance on NAC's supplement status.

What are the most studied benefits of NAC?

NAC is best studied for glutathione replenishment (antioxidant support), respiratory health (mucolytic properties), liver support (hepatoprotection), and emerging evidence for mood support. Its role in acetaminophen toxicity treatment is the gold-standard medical use.

What dosage of NAC is used in clinical studies?

Most supplement-focused studies use 600–1,200 mg/day, often in divided doses. Some research uses up to 1,800 mg/day. Higher doses are typically used in clinical/hospital settings for acute indications.

Stop Spending Weeks on Substantiation

Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.

Join the Waitlist